SynsorBio was founded in June 2020. We integrate R&D, manufacture, and sales of diagnostic reagents, NGS products and instruments. We use CRISPR as a core technology, with the combination of Microfluidics and Synthetic biology, to focus on the original R&D of emerging molecular biological techniques, together with R&D and applications of Point-of-care testing (POCT). We have obtained the authorization of CRISPR/Cas detection, which have already been industrialized into products. Moreover, we have also launched products related to NGS sample preparation, to meet the various needs of our customers.

The R&D center is located in VPark in Beijing Economic and Technological Development Area, with an R&D and operation center covering an area of nearly 1,000 m². At the same time, a modern integrated base including R&D, production and service has been built in Shaoxing, Zhejiang Province, with supporting production, logistics and service systems to ensure the strategic layout and business development needs.